Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer

Zebin Liu; Lipeng Lin; Guosheng Zhu; Liying Qiu

doi:doi:10.11648/j.cmr.20241301.12

Research Article |

| Peer-Reviewed

Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer

Zebin Liu, Lipeng Lin, Guosheng Zhu, Liying Qiu^*

Published in Clinical Medicine Research (Volume 13, Issue 1)

Received: 17 December 2023 Accepted: 28 December 2023 Published: 8 January 2024

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer

Published in	Clinical Medicine Research (Volume 13, Issue 1)
DOI	10.11648/j.cmr.20241301.12
Page(s)	6-12
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Breast Cancer, Machine Learning, FER, CEA, CA153, CY211, Clinical Prediction Model

References

[1]	Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology. 2021; 95. doi: 10.1259/bjr.20211033.
[2]	Di Sibio A, Abriata G, Forman D, Sierra MS. Female breast cancer in Central and South America. Cancer Epidemiol. 2016; 44 Suppl 1: S110-S120. doi: 10.1016/j.canep.2016.08.010.
[3]	Duffy MJ, et al. Tumor markers in breast cancer: Guidelines for use and interpretation in the clinical setting. European Journal of Cancer. 2005; 41(9): 1343-1357. doi: 10.1016/j.ejca.2005.02.025.
[4]	K. Pantel, "Abstract PL01-01: Liquid biopsy: Novel technologies and clinical applications", Clinical Research (Excluding Clinical Trials), 2018. DOI: 10.1158/1538-7445. AM2018-PL01-01.
[5]	M. Zubair, S. Wang, N. Ali, "Advanced Approaches to Breast Cancer Classification and Diagnosis", Frontiers in Pharmacology, 2021. DOI: 10.3389/fphar.2020.632079.
[6]	Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiol Clin North Am. 2017; 55(6): 1145-1162. doi: 10.1016/j.rcl.2017.06.004.
[7]	Gulshan V, Peng L, Coram M, et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA. 2016; 316(22): 2402-2410. doi: 10.1001/jama.2016.17216.
[8]	Lakhani P, Prater AB, Hutson RK, et al. Machine Learning in Radiology: Applications Beyond Image Interpretation. J Am Coll Radiol. 2018; 15(2): 350-359. doi: 10.1016/j.jacr.2017.09.044.
[9]	Savarese TM, Strohsnitter WC, Low HP, et al. Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res. 2007; 9(3): R29. doi: 10.1186/bcr1674.
[10]	Giovanella L, Ceriani L, Giardina G, et al. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Clin Chem Lab Med. 2002; 40(3): 298-303. doi: 10.1515/CCLM.2002.047.
[11]	Tarighati E, Keivan H, Mahani H. A review of prognostic and predictive biomarkers in breast cancer. Clin Exp Med. 2023; 23(1): 1-16. doi: 10.1007/s10238-021-00781-1.
[12]	Fadavi P, Nafisi N, Hariri R, et al. Serum Ferritin, Vitamin D and Pathological Factors in Breast Cancer Patients. Med J Islam Repub Iran. 2021; 35: 162. Published 2021 Dec 6. doi: 10.47176/mjiri.35.162.
[13]	Alkhateeb AA, Han B, Connor JR. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat. 2013; 137(3): 733-744. doi: 10.1007/s10549-012-2405-x.
[14]	Duffy MJ, Shering S, Sherry F, et al. CA 15-3: a prognostic marker in breast cancer. Int J Biol Markers. 2000; 15(4): 330-333. doi: 10.1177/172460080001500410.
[15]	Wojtacki J, Kruszewski WJ, Sliwińska M, et al. Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases. Przegl Lek. 2001; 58(6): 498-503.
[16]	Tampellini M, Berruti A, Bitossi R, et al. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. Breast Cancer Res Treat. 2006; 98(3): 241-248. doi: 10.1007/s10549-005-9155-y
[17]	Nakata B, Takashima T, Ogawa Y, et al. Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer. Br J Cancer. 2004; 91(5): 873-878. doi: 10.1038/sj.bjc.6602074.
[18]	Zhou L, Ren Y, Wang X, et al. Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient- a case report. Onco Targets Ther. 2019; 12: 5305-5309. Published 2019 Jul 4. doi: 10.2147/OTT.S206732.

Cite This Article

Plain Text BibTeX RIS

APA Style

Liu, Z., Lin, L., Zhu, G., Qiu, L. (2024). Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clinical Medicine Research, 13(1), 6-12. https://doi.org/10.11648/j.cmr.20241301.12

Copy | Download

ACS Style

Liu, Z.; Lin, L.; Zhu, G.; Qiu, L. Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clin. Med. Res. 2024, 13(1), 6-12. doi: 10.11648/j.cmr.20241301.12

Copy | Download

AMA Style

Liu Z, Lin L, Zhu G, Qiu L. Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clin Med Res. 2024;13(1):6-12. doi: 10.11648/j.cmr.20241301.12

Copy | Download

@article{10.11648/j.cmr.20241301.12,
  author = {Zebin Liu and Lipeng Lin and Guosheng Zhu and Liying Qiu},
  title = {Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer},
  journal = {Clinical Medicine Research},
  volume = {13},
  number = {1},
  pages = {6-12},
  doi = {10.11648/j.cmr.20241301.12},
  url = {https://doi.org/10.11648/j.cmr.20241301.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20241301.12},
  abstract = {Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer
AU  - Zebin Liu
AU  - Lipeng Lin
AU  - Guosheng Zhu
AU  - Liying Qiu
Y1  - 2024/01/08
PY  - 2024
N1  - https://doi.org/10.11648/j.cmr.20241301.12
DO  - 10.11648/j.cmr.20241301.12
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 6
EP  - 12
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20241301.12
AB  - Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer

VL  - 13
IS  - 1
ER  -

Copy | Download

Author Information

Zebin Liu

Laboratory Department, Shenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen, China
Lipeng Lin

Laboratory Department, Shenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen, China
Guosheng Zhu

Laboratory Department, Shenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen, China
Liying Qiu

Laboratory Department, Shenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen, China

Contact Email

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Liu, Z., Lin, L., Zhu, G., Qiu, L. (2024). Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clinical Medicine Research, 13(1), 6-12. https://doi.org/10.11648/j.cmr.20241301.12

Copy | Download

ACS Style

Liu, Z.; Lin, L.; Zhu, G.; Qiu, L. Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clin. Med. Res. 2024, 13(1), 6-12. doi: 10.11648/j.cmr.20241301.12

Copy | Download

AMA Style

Liu Z, Lin L, Zhu G, Qiu L. Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer. Clin Med Res. 2024;13(1):6-12. doi: 10.11648/j.cmr.20241301.12

Copy | Download

@article{10.11648/j.cmr.20241301.12,
  author = {Zebin Liu and Lipeng Lin and Guosheng Zhu and Liying Qiu},
  title = {Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer},
  journal = {Clinical Medicine Research},
  volume = {13},
  number = {1},
  pages = {6-12},
  doi = {10.11648/j.cmr.20241301.12},
  url = {https://doi.org/10.11648/j.cmr.20241301.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20241301.12},
  abstract = {Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer
AU  - Zebin Liu
AU  - Lipeng Lin
AU  - Guosheng Zhu
AU  - Liying Qiu
Y1  - 2024/01/08
PY  - 2024
N1  - https://doi.org/10.11648/j.cmr.20241301.12
DO  - 10.11648/j.cmr.20241301.12
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 6
EP  - 12
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20241301.12
AB  - Combining Multiple Tumor Markers to Construct a Clinical Prediction Model for Breast Cancer

VL  - 13
IS  - 1
ER  -

Copy | Download